TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | -8 | 18 | 2 | 50 | 86 | 25 |
| P | %wins | 50 | 0 | 100 | 50 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/14 10:10 | 5/5/14 | MACK | Merrimack Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mulroy Robert J. | MA | DO | P,CEO | P | 32 | 6.31 | 19 | 5 | 1 | 946 | D | -10 | 62 | 182 | 37 | 29 | 56 | 54 | -2 | -1 | -4 | 10 | -14 | 33 | 63 |
12/5/13 10:30 | 12/4/13 | MACK | Merrimack Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mulroy Robert J. | MA | DO | P,CEO | P | 146 | 4.42 | 9 | 33 | 3 | 990 | D | -35 | -7 | 21 | 36 | 86 | 49 | 17 | 3 | -12 | 26 | 18 | 67 | 108 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |